<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H674AA02D1B0A42AEBB01008C994F8FCD" public-private="public">
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>110 HR 1249 IH: To include dehydroepiandrosterone as an anabolic
</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2007-02-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
	<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>110th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 1249</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20070228">February 28, 2007</action-date>
			<action-desc><sponsor name-id="R000580">Mr. Roskam</sponsor> introduced
			 the following bill; which was referred to the
			 <committee-name committee-id="HIF00">Committee on Energy and
			 Commerce</committee-name>, and in addition to the Committee on the
			 <committee-name committee-id="HJU00">Judiciary</committee-name>, for a period
			 to be subsequently determined by the Speaker, in each case for consideration of
			 such provisions as fall within the jurisdiction of the committee
			 concerned</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To include dehydroepiandrosterone as an anabolic
		  steroid.</official-title>
	</form>
	<legis-body id="HFA65E39585204656BB7B344490696154" style="OLC">
		<section display-inline="no-display-inline" id="H7704785C2A67458B9C650989CE9607BD" section-type="section-one"><enum>1.</enum><header>Inclusion of
			 dehydroepiandrosterone</header><text display-inline="no-display-inline">Section
			 102(41)(A) of the <act-name parsable-cite="CSA">Controlled Substances
			 Act</act-name> (<external-xref legal-doc="usc" parsable-cite="usc/21/802">21 U.S.C. 802(41)(A)</external-xref>) is amended—</text>
			<paragraph id="HB4A1D64E7633428DAF30C3788B9EA86C"><enum>(1)</enum><text>in the matter
			 preceding clause (i), by striking <quote>corticosteroids, and
			 dehydroepiandrosterone</quote> and inserting <quote>and
			 corticosteroids</quote>;</text>
			</paragraph><paragraph id="H527CA5A37AF44B5092DB83AFFEEA3700"><enum>(2)</enum><text>by redesignating
			 clauses (x) through (xlx) as clauses (xi) through (xlxi), respectively;
			 and</text>
			</paragraph><paragraph id="HAA3D0905EDF349D3908E1EB87FDABB0"><enum>(3)</enum><text>by
			 inserting after clause (ix) the following:</text>
				<quoted-block id="HA8EEC003609A40FDA52DBB5897F69433">
					<clause id="H2B4C30FF9BF5446996DE1C9BA392E951" indent="up2"><enum>(x)</enum><text>dehydroepiandrosterone
				(androst-5-en-3β-ol-17-one);</text>
					</clause><after-quoted-block>.</after-quoted-block></quoted-block>
			</paragraph></section></legis-body>
</bill>


